EGFR and Stroke: Specifically, patients with mutations in EGFr 1–6 had an earlier age of stroke onset by 12 years, shorter survival, and increased white matter high-signal volume compared with patients with mutations in EGFr 7–34, which is consistent with a previous study in Japan (33).